References
- Bachynsky N: The use of anticholinergic drugs for smok-ing cessation: A pilot study. Int J Addict 1986; 21:789–805.
- Pappano AJ, Katzung BG: Cholinoceptor-blocking drugs. In: Katztmg BG, ed. Basic and clinical pharmacology, 8th ed. New York: McGraw-Hill; 2001: 107–119.
- Peters, ML: Snipping the thread of life: Antimuscarinic side effects of medications in the elderly. Arch Intern Med 1989; 149:2414–2420.
- Meyer JM, Simpson GM: Anticholinergics and Amanta-dine. In: Sadock BJ, Sadock VA, eds. Kaplan & Sadock's comprehensive textbook of psychiatry, 7th ed. Baltimore: Lippincott Williams & Wilkins; 2000: 2276–2282.
- Mintzer J, Burns A: Anticholinergic side-effects of drugs in elderly people. J R Soc Med 2000; 93: 457–462.
- Sadock BJ, Sadock VA: Kaplan and Sadock's synopsis of psychiatry behavioral sciences/clinical psychiatry, 9th ed. Philadelphia: Lippincott Williams and Wilkins; 2003.
- Silberstein SD, Peres MFP, Hopkins MM, Shechter AL, Young WB, Rozen TD: Olanzapine in the treat-ment of refractory migraine and chronic daily headache. Headache 2002; 42:515–518.
- Zorn SH, Jones SB, Ward KM, Liston DR: Clozapine is a potent and selective muscarinic M4 receptor agonist. Eur J Pharmacol 1994; 269:R1–2.
- Nilsson E: Physostigmine treatment in various drug-induced intoxications. Ann Clin Res 1982; 14:165–172.
- Ziskind AA: Transdermal scopolamine-induced psy-chosis. Postgrad Med 1988; 84:73–76.
- Noyan MA, Elbi H, Aksu H: Donepezil for anticholin-ergic drug intoxication: A case report. Prog Neuro-Psychoph 2003; 27:885–887.
- MacEwan GW, Remick RA, Noone JA: Psychosis due to transdermally administered scopolamine. Can Med Assoc J1985; 133:431–432.
- Marchlewski MB: Anticholinergic syndrome: Avoiding misdiagnosis. J Psychosoc Nurs 1994; 32:22–24.
- Minagar A, Shulman LM, Weiner WJ: Transderm-induced psychosis in Parkinson's disease. Neurology 1999; 53:433–434.
- Patten SB, Williams JV, Petcu R, Oldfield R: Delirium in psychiatric inpatients: a case-control study. Can J Psychiatry 2001; 46:162–166.
- Sennhauser FJ, Schwarz HP: Toxic psychosis from trans-dermal scopolamine in a child. Lancet 1986; 2:1033.
- Birkimer LJ, Jacobson PA, Olson J, Goyette DM: Ocular scopolamine-induced psychosis. J Fam Pract 1984; 18:464–469.
- Ostherholm, RK, Camoriano JK: Transdermal scopol-amine psychosis. JAMA 1982; 247:3081.
- Mego DM, Omori DJM, Hanley JF: Transdermal scopolamine as a cause of transient psychosis in two elderly patients. South Med J1988; 81:394–395.
- Janicak PG, Davis JM, Preskorn SH, Ayd FJ: Princi-ples and practice of psychopharmacotherapy. Philadel-phia: Lippincott Williams & Wilkins; 2001:215–325.
- Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ: A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972; 2:632–635.
- Thase ME: Mood Disorders: Neurobiology. In: Sadock BJ, Sadock VA, eds. Kaplan and Sadock's comprehen-sive textbook of psychiatry, 7th ed. Philadelphia: Lippincott William & Wilkins; 2000: 1318–1328.